News & Media

Take a closer look at what we’re doing across Teva worldwide

Press releases

New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European ...

New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Acade

Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Facto...

Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors Ma

Teva Announces the U.S. Launch of its Generic Version of SOOLANTRA® (ivermectin) Cream, 1% for Once ...

Teva Announces the U.S. Launch of its Generic Version of SOOLANTRA® (ivermectin) Cream, 1% for Once Daily

New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection Present...

New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection Presented at

Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache So...

Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society

Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets

Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets

Teva Launches It’s Not OK – It’s TD National Television Advertising Campaign to Increase Awareness o...

Teva Launches It’s Not OK – It’s TD National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia and AUSTEDO® (deutetrabenazine) tablets

Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society Internatio...

Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International C

Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report

Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report

Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of...

Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bact
See all press releases
Previous
Next

Top Stories

Read the latest Teva news

Levana Volovsky - Director, Global Regulatory Bridges the Health Equity Gap for Women with MS

Levana Volovsky - Director, Global Regulatory Bridges the Health Equity Gap for Women with MS

Out of the Limelight: Supporting Millions of Non-COVID Patients in Their Journey Back to Healthcare

Out of the Limelight: Supporting Millions of Non-COVID Patients in Their Journey Back to Healthcare

Celebrating Cultural Diversity at Teva

Celebrating Cultural Diversity at Teva

Meet the Expert - Susie Freda

Meet the Expert - Susie Freda

“This ‘invisible pandemic’ is one of the biggest global health challenges”

“This ‘invisible pandemic’ is one of the biggest global health challenges”

Introducing Teva USA’s HBA Rising Stars & Luminary

Introducing Teva USA’s HBA Rising Stars & Luminary

The secret to achieving our new environmental targets? Our people

The secret to achieving our new environmental targets? Our people

The hidden impact of migraine on millions of women

The hidden impact of migraine on millions of women

"Bringing more women and more diversity into our leadership makes us stronger."

"Bringing more women and more diversity into our leadership makes us stronger."

Meet the Expert: Professor Ruth Arnon

Meet the Expert: Professor Ruth Arnon
View all stories

Media Resources

Intended for use by media professionals; may be downloaded for non-commercial use 

Media Inquiries

Contact our corporate communications.

Learn more Media Inquiries

Media Kit

Files and resources for media use only

Download Teva Media Kit Media Kit

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports

Connect with us

Teva Social Media Guidelines.

Learn more Connect with us